TriClip CED RWE Study

Recruiting now

Conditions studied: Tricuspid Regurgitation

In brief

This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.

Key facts

Study ID

NCT06920745

Run by

Abbott Medical Devices

People needed

2200

Starts

2025-07-08

Expected to finish

2032-07-01

Last updated by the study team

2025-08-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients ≥ 18 years of age at time of implant
• Patients with symptomatic, severe or greater Tricuspid Regurgitation who have received the TriClip system (treatment group) or have not undergone T-TEER (control group)

You may not qualify if…

• Patients with less than severe Tricuspid Regurgitation
• Patients with a prior history of surgical or transcatheter tricuspid valve replacement
• Patients with a surgical or transcatheter aortic or mitral valve intervention within 90 days prior to index

Where it is running

• Abbott — Santa Clara, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.